At first glance, rheumatoid arthritis and coronavirus have little in common. But an underlying pathological mechanism that involves an over-reactive immune response may allow a drug developed to treat arthritis to save the lives of coronavirus victims.
We have yet another tragic flu story in the news. This time it's a 38-year old mother who died because she thought the flu drug she was prescribed was too expensive. The only problem? The media got everything wrong. The flu drug would not have made any difference.